160 related articles for article (PubMed ID: 6876683)
1. Myasthenia gravis: overlap with 'polyendocrine' autoimmunity.
Scherbaum WA; Schumm F; Maisch B; Müller C; Fateh-Moghadam A; Flüchter SH; Seif FJ; Bottazzo GF; Berg PA
Klin Wochenschr; 1983 May; 61(10):509-15. PubMed ID: 6876683
[TBL] [Abstract][Full Text] [Related]
2. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
[TBL] [Abstract][Full Text] [Related]
3. HLA antigens and acetylcholine receptor antibody in the subclassification of myasthenia gravis in Hong Kong Chinese.
Hawkins BR; Ip MS; Lam KS; Ma JT; Wy CL; Yeung RT; Dawkins RL
J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):316-9. PubMed ID: 3958744
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types.
Kida K; Hayashi M; Yamada I; Matsuda H; Yoshinaga J; Takami S; Yashiki S; Sonoda S
Ann Neurol; 1987 Mar; 21(3):274-8. PubMed ID: 3606034
[TBL] [Abstract][Full Text] [Related]
5. [Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters].
Grosse-Wilde H; Toyka KV; Besinger UA; Doxiadis I; Heininger K; Hömberg M; Hömberg V; Hohlfeld R; Fateh-Moghadam A; Jungwirth J; Kreeb G; Vögeler U
Dtsch Med Wochenschr; 1983 May; 108(18):694-700. PubMed ID: 6839994
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis.
Klein R; Marx A; Ströbel P; Schalke B; Nix W; Willcox N
Hum Immunol; 2013 Sep; 74(9):1184-93. PubMed ID: 23792059
[TBL] [Abstract][Full Text] [Related]
7. The autoimmune spectrum of myasthenia gravis: a Swedish population-based study.
Fang F; Sveinsson O; Thormar G; Granqvist M; Askling J; Lundberg IE; Ye W; Hammarström L; Pirskanen R; Piehl F
J Intern Med; 2015 May; 277(5):594-604. PubMed ID: 25251578
[TBL] [Abstract][Full Text] [Related]
8. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
Garlepp MJ; Dawkins RL; Christiansen FT
Br Med J (Clin Res Ed); 1983 Jan; 286(6362):338-40. PubMed ID: 6402089
[TBL] [Abstract][Full Text] [Related]
9. Antiacetylcholine receptor and antinuclear antibodies in myasthenia gravis. Correlation with HLA, sex and Gm.
Warlow RS; Garlepp M; Feeney D; Kay P; Swanson N; Dawkins RL
Exp Clin Immunogenet; 1985; 2(3):158-63. PubMed ID: 3917146
[TBL] [Abstract][Full Text] [Related]
10. Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity.
Massa R; Greco G; Testi M; Rastelli E; Terracciano C; Frezza E; Garibaldi M; Marfia GA; Locatelli F; Mercuri NB; Pompeo E; Antonini G; Andreani M
J Neurol; 2019 Apr; 266(4):982-989. PubMed ID: 30741378
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles.
Vincent A; Newsom-Davis J
Clin Exp Immunol; 1982 Aug; 49(2):257-65. PubMed ID: 6813004
[TBL] [Abstract][Full Text] [Related]
12. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
[TBL] [Abstract][Full Text] [Related]
13. HLA, anti-DNA, and complement in myasthenia gravis.
Christiansen FT; Houliston JB; Dawkins RL
Muscle Nerve; 1978; 1(6):467-70. PubMed ID: 757869
[TBL] [Abstract][Full Text] [Related]
14. Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice.
Wu X; Tuzun E; Saini SS; Wang J; Li J; Aguilera-Aguirre L; Huda R; Christadoss P
Immunol Lett; 2015 Dec; 168(2):306-12. PubMed ID: 26493475
[TBL] [Abstract][Full Text] [Related]
15. Antiacetylcholine receptor antibody and its relationship to HLA type in asymptomatic siblings of a patient with myasthenia gravis.
Seybold ME; Lindstrom JM
Neurology; 1981 Jun; 31(6):778-80. PubMed ID: 7195498
[TBL] [Abstract][Full Text] [Related]
16. Familial myasthenia gravis.
Honeybourne D; Dyer PA; Mohr PD
J Neurol Neurosurg Psychiatry; 1982 Sep; 45(9):854-6. PubMed ID: 7131024
[TBL] [Abstract][Full Text] [Related]
17. Poly-autoimmunity in patients with myasthenia gravis: A single-center experience.
Evoli A; Caliandro P; Iorio R; Alboini PE; Damato V; LaTorre G; Provenzano C; Marino M; Lauriola L; Scuderi F; Bartoccioni E
Autoimmunity; 2015; 48(6):412-7. PubMed ID: 25868386
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis, a model of organ-specific autoimmune disease.
Berrih-Aknin S
J Autoimmun; 1995 Apr; 8(2):139-43. PubMed ID: 7612144
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholine receptor antibody characteristics in myasthenia gravis. III. Patients with low anti-AChR antibody levels.
Vincent A; Newsom-Davis J
Clin Exp Immunol; 1985 Jun; 60(3):631-6. PubMed ID: 2410169
[TBL] [Abstract][Full Text] [Related]
20. Anti-acetylcholine receptor antibodies.
Vincent A; Newsom Davis J
J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):590-600. PubMed ID: 7400823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
